Literature DB >> 8012955

Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.

H M Clark1, T Yano, T Otsuki, E S Jaffe, D Shibata, M Raffeld.   

Abstract

Our previous studies of the translocated MYC gene in Burkitt's lymphoma showed the existence of clustered somatic mutations located in the transcriptional activation domain. We now report that aggressive lymphomas arising in the acquired immunodeficiency syndrome (AIDS) contain similar mutations and that the presence of mutations is correlated with the rearrangement of the oncogene. Mutations were also found in other de novo non-AIDS, non-Burkitt's aggressive lymphomas with MYC rearrangements. An unusual asparagine to serine mutation at codon 11 was identified in several transformed follicular lymphomas without MYC rearrangement but not in normal tissues from patients with this mutation. These findings indicate that AIDS-associated and other de novo aggressive lymphomas with the MYC gene rearrangement are subject to the same mutation and selection process that affects Burkitt's lymphomas.

Entities:  

Mesh:

Year:  1994        PMID: 8012955

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 4.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

Review 5.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

6.  Myc: the beauty and the beast.

Authors:  Amanda R Wasylishen; Linda Z Penn
Journal:  Genes Cancer       Date:  2010-06

7.  Base-Pairing Energies of Protonated Nucleoside Base Pairs of dCyd and m(5)dCyd: Implications for the Stability of DNA i-Motif Conformations.

Authors:  Bo Yang; M T Rodgers
Journal:  J Am Soc Mass Spectrom       Date:  2015-05-22       Impact factor: 3.109

8.  COP1 is a tumour suppressor that causes degradation of ETS transcription factors.

Authors:  Alberto C Vitari; Kevin G Leong; Kim Newton; Cindy Yee; Karen O'Rourke; Jinfeng Liu; Lilian Phu; Rajesh Vij; Ronald Ferrando; Suzana S Couto; Sankar Mohan; Ajay Pandita; Jo-Anne Hongo; David Arnott; Ingrid E Wertz; Wei-Qiang Gao; Dorothy M French; Vishva M Dixit
Journal:  Nature       Date:  2011-05-15       Impact factor: 49.962

9.  LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation.

Authors:  Pengfei Zhang; Limian Cao; Pingsheng Fan; Yide Mei; Mian Wu
Journal:  EMBO Rep       Date:  2016-06-17       Impact factor: 8.807

10.  MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation.

Authors:  Sarah Anderson; Kumud Raj Poudel; Minna Roh-Johnson; Thomas Brabletz; Ming Yu; Nofit Borenstein-Auerbach; William N Grady; Jihong Bai; Cecilia B Moens; Robert N Eisenman; Maralice Conacci-Sorrell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.